RE: MCAP £260M21 May 2021 10:40
It's the vague woolly nature of these rns that are the issue, the market hates them. They need to put a figure on the dispute and then we can move on for good or bad. They won't though and once again we are left scrabbling around trying to quantify it ourselves which is just completely unacceptable, it's beyond belief that he's done this again.
In the meantime we haven't been told of a meaningful contract since September, donated a huge number of tests gratis to unicef and he received an enormous bonus which now represents more than 1% of our mcap for delivering dumpster fire rns after rns.
Why is there no update on this antigen LFT which we're supposedly launching by end Q2, it is incredulous to me that they don't at least have something to say about it's progress while we're waiting I assume for a CE mark but no, nothing.
What about an update on overseas sales? Nada.
I wouldn't go as far as to say inept but out of his depth certainly. No wonder the IIs won't touch us with a bargepole, institutional interest is pitiful, good luck trying to get your next bonus voted through GM.